Close
CDMO Safety Testing 2026
Novotech

Almac Group Announces $65M Expansion of North American Headquarters in Pennsylvania

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.
- Advertisement -

Almac Group, the global contract development and manufacturing organisation, today announces a $65 million, 100,000 ft2expansion of clinical supply operations at the companyโ€™s North American headquarters in Souderton, PA. The capital investment plan increases clinical capacity at the facility by 60%, with additional cold and ultra-low storage and just-in-time processing capabilities which is forecasted to support the industry trend towards biologics and advanced therapeutic medicinal products (ATMPs).

This investment enables Almac to better support the North American market โ€“ Robert Dunlop, President and Managing Director, Almac Clinical Services, commented: โ€œDrug development and clinical trials continue to evolve across the world, with sponsors expanding their pipelines to focus on biologics, vaccines and advanced therapy medicinal products. Almac is at the forefront of building supply chain expertise and capacity for this evolution. We are committed to investing in our clientsโ€™ future challenges and are delighted that this expansion provides us with a stronger ability to service our growing customer base.โ€

The North American Headquarters expansion comes on the heels of the companyโ€™s July announcement that the overall planned investment in Pennsylvania operations and facilities will total $93.5 million over the next three years and will total over $250 million for the Group globally during the same period.

The company has committed to creating 355 new Montgomery County-based jobs to support the forecasted growth and is actively recruiting for positions across disciplines and experience levels.

Acting Secretary of Economic and Community Development Neil Weaver today visited Almacโ€™s North American headquarters to mark the next chapter of growth for the company and local community.

โ€œItโ€™s a thrill to be here today to see first-hand what Almac has planned for their expansion, and Iโ€™m glad that DCED and the Wolf Administration could assist with these plans and invest in this project,โ€ said Weaver. โ€œThis project is bringing good paying jobs to the region and shows what Pennsylvania has to offer to companies, especially in the life sciences. This state, and this area, continues to be a worldwide leader in the biotech and life sciences industries.

Latest stories

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.

Quantum Computing Optimizing Pharma Supply Chains

The global distribution of pharmaceutical products is facing unprecedented challenges that demand a new level of logistical precision and resilience. By utilizing advanced analytical models, companies can now navigate complex international networks with greater efficiency, ensuring that temperature-sensitive medicines and life-saving therapies reach their destinations without delay. This evolution toward a more intelligent and responsive supply chain is critical for maintaining public health and responding effectively to emerging medical needs on a global scale.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป